Biotechnology

#Antibodies #Biotechnology

Sterling announces strategic investment in ADC Biotechnology

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based biotechnology company specialising in antibody drug conjugates. The partnership will see Sterling make a significant investment in the business with a view to acquiring ADC… Read More

#News

#Biotechnology #Clinical trials

Oxeia Biopharmaceuticals announces Phase II trial for concussion treatment

Oxeia Biopharmaceuticals is a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury. It has announced the initiation of a Phase II clinical trial of OXE103 for treating concussion. The Phase II clinical study is being conducted by Dr. Michael Rippee,… Read More

#News

#Biotechnology #Drug development #Drug discovery #Life sciences #Narrated podcasts #Pharmaceutical #Research

Evolution of User Experience for life sciences

Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centres on the behaviours and needs of users. The clear benefits of UX offered in the retail and consumer sectors have been slow to… Read More

#Podcasts

#Biotechnology #Oncology #Therapeutics

STORM Therapeutics uses Evotec platform to push oncology project towards clinical studies

STORM Therapeutics will use INDiGO, Evotec’s integrated, accelerated IND-enabling platform, to progress its STC-15 towards an IND application in 2021. STORM, a biotechnology company focused on the discovery and development of small molecule therapies modulating RNA epigenetics, has selected STC-15 as a first-in-class development candidate. STORM discovered STC-15, an orally… Read More

#Cancer Research #News

#Biotechnology #Drug development #Drug discovery #Ingredients / APIs / Fine chemicals #Pharmacokinetics / Pharmacodynamics

Evotec expands UK site into drug discovery & development centre

Evotec is expanding its campus in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development centre to be named Dorothy Crowfoot Hodgkin Campus. Adding a new building, which will house up to 100 biologists by the end of the year, will bring together all the key functions for… Read More

#News

#Biotechnology #Drug development #Drug discovery #Narrated podcasts #Pharmaceutical

Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic

Non-alcoholic fatty liver disease (NAFLD) has quietly become one of the most common causes of chronic liver disease in the modern world. If this prevalence is allowed to continue the economic and clinical burden will reach a staggering level. Non-alcoholic fatty liver disease (NAFLD) consists of a complex combination of… Read More

#Podcasts

#Biotechnology #Drug discovery #Drug targets #Hit identification #Immunotherapy #Oncology

Partnership will progress targeted cancer immune therapy drug discovery

APEIRON Biologics, a biotech company developing breakthrough therapies to treat cancer and respiratory conditions, has selected Domainex to provide integrated lead optimisation services in order to advance the development of inhibitors for the E3 ubiquitin ligase Cbl-b through small molecule drug discovery. Under the terms of the agreement, Domainex, an… Read More

#Cancer Research #News

#Biotechnology #Drug development #Drug discovery #Life sciences #Narrated podcasts #Pharmaceutical

Reducing the PAINS in High Throughput Screening: Assay design as a tool for maximising efficiency

This article will describe, with examples, how understanding the likely mechanisms of false positives in advance of screening informs the design of the hit triage, thus increasing the likelihood of discovering optimisable chemical matter and avoiding costly wasting of resource. We describe the use of a bespoke ‘Robustness Set’ of… Read More

#Podcasts